Clinical Trial Detail

NCT ID NCT02537223
Title Phase I Study of BYL719 in Combination With Cisplatin and Radiotherapy in Patients With Squamous Cell Head and Neck Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University Health Network, Toronto
Indications

head and neck squamous cell carcinoma

Therapies

Alpelisib

Cisplatin

Age Groups: adult

No variant requirements are available.